Human cortical fibroblast responses to high glucose and hypoxia

Nephron - Physiology

Volumn 96, Issue 4, 2004, Pages

  Qi, Weier ^a   Poronnik, Philip ^a,d   Young, Barbara ^b   Jackson, Chris J ^b   Field, Michael J ^c   Pollock, Carol A ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Fibroblast; Matrix metalloproteinases; Plasminogen activator inhibitor; Tissue inhibitor matrix metalloproteinases

Indexed keywords

CELL PROTEIN; GELATINASE A; GELATINASE B; GLUCOSE; TISSUE INHIBITOR OF METALLOPROTEINASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOXIA; KIDNEY CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL COUNT; CELL HYPOXIA; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM;

CELL COUNT; CELL HYPOXIA; CELLS, CULTURED; FIBROBLASTS; GLUCOSE; HUMANS; KIDNEY CORTEX; MATRIX METALLOPROTEINASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 2342512909     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077383     Document Type: Article

References (21)

1. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999;56:393-405.
2. Fornoni A, Striker LJ, Zheng F, Striker GE: Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background. Diabetes 2002;51:499-505.
3. Ye S: Polymorphism in matrix metalloproteinase gene promoters: Implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000;19:623-629.
4. De Cosmo S, Tassi V, Thomas S, Piras GP, Trevisan R, Cavallo Perin P, Bacci S, Zucaro L, Cisternino C, Trischitta V, Viberti GC: The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron 2002;92:72-76.
5. Fornoni A, Wang Y, Lenz O, Striker LJ, Striker GE: Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice. J Am Soc Nephrol 2002;13:2068-2076.
6. Jones SC, Saunders HJ, Pollock CA: High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells. Diab Med 1999;16:932-938.
7. Grupp C, Muller GA: Renal fibroblast culture. Exp Nephrol 1999;7:377-385.
8. Eddy AA: Plasminogen activator inhibitor-1 and the kidney. Am J Physiol 2002;283:F209-220.
9. Norman JT, Clark IM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000;58:2351-2366.
10. Johnson DW, Saunders HJ, Brew BK, Ganesan A, Baxter RC, Poronnik P, Cook DI, Gyory AZ, Field MJ, Pollock CA: Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney Int 1997;52:1486-1496.
11. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 1998;54:747-757.
12. Jones SC, Saunders HJ, Qi W, Pollock CA: Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 1999;42:1113-1119.
13. Han DC, Isono M, Hoffman BB, Ziyadeh FN: High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGFbeta. J Am Soc Nephrol 1999;10:1891-1899.
14. Maeda S, Haneda M, Guo B, Koya D, Hayashi K, Sugimoto T, Isshiki K, Yasuda H, Kashiwagi A, Kikkawa R: Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int 2001;60:1428-1434.
15. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ: High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 2001;9:249-257.
16. McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE: Decreased matrix degradation in diabetic nephropathy: Effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002;45:268-275.
17. Suzuki D, Yagame M, Kim Y, Sakai H, Mauer M: Renal in situ hybridization studies of extracellular matrix related molecules in type 1 diabetes mellitus. Nephron 2002;92:564-572.
18. Kanauchi M, Nishioka H, Nakashima Y, Hashimoto T, Dohi K: Role of tissue inhibitors of metalloproteinase in diabetic nephropathy. Nippon Jinzo Gakkai Shi 1996;38:124-128.
19. Kim H, Oda T, Lopez-Guisa J, Wing D, Edwards DR, Soloway PD, Eddy AA: TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2001;12:736-748.
20. Norman JT, Orphanides C, Garcia P, Fine LG: Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol 1999;7:463-469.
21. Melin J, Hellberg O, Akyurek LM, Kallskog O, Larsson E, Fellstrom BC: Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int 1997;52:985-991.